AstraZeneca and the Dreaded ‘Clot-shot’

Oh what a tangled web we weave...

During the last five days newspapers in the United Kingdom (UK) have announced two test cases have been filed in the High Court against Covid-19 injectable manufacturer AstraZeneca (AZ). The two cases are brought by the husband of deceased AZ recipient Alpa Tailor who died after clots and bleeds on her brain, and Jamie Scott who suffered debilitating life-changing permanent disabilities after a catastrophic bleed on his own brain. In both cases the clots and bleeds have been diagnosed as vaccine induced immune thrombosis and thrombocytopaenia (VITT). VITT is recognised as a known serious adverse event (SAE) from the AZ Covid-19 injectable product. Both cases are product liability or ‘damages’ claims that allege the AZ product was ‘defective’.

Public figures from Adam Finn, a professor in paediatrics at the University of Bristol and member of the UK’s Joint Committee on Vaccination and Immunisation (JVCI) and David Spiegelhalter, Professor Emeritus of Statistics at the University of Cambridge, repeatedly told their audiences of press and social media followers that the issue was infinitessimally rare; certainly less so than the potential risks from Covid-19 itself - which is a claim we now know was completely falacious.

In fact, even after far more suitably qualified scientists in Europe had accepted evidence for the issue and identified a potential cause, Speigelhalter published an article in The Guardian claiming that there ‘was no proof the Oxford vaccine causes blood clots’.

Well David, that article didn’t age well.

So I ask the question…

Does rare really mean ‘rare’?

You might be forgiven for believing the mainstream media and medicines regulators when they repeatedly stated that the thromboembolic adverse events claimed by the two victims in the current High Court test case, and the other potential claimants - at least 19 fatal adverse reactions and 54 who suffered adverse events but survived in this one proposed follow-up class action case, are rare.

However, there was already awareness of and ongoing investigations into the correlation between clotting and the AZ product as early as mid-March 2021, only two-and-a-half months after the European Medicines Authority (EMA) had given conditional marketing authority (CMA) for administration of ChadOx1 in EU countries. In March 2021 German and Norwegian researchers claimed it was a ‘rare autoimmune reaction’ that caused the clots, and suggested a possible treatment for it. At the time of writing I could not locate a clinical practice guideline in the UK that actually supported the use of their proposed treatment approach. By April 2021 and even as Denmark, the first of over fifteen European countries to do so, were withdrawing the AZ product from use, even the EMA were treading carefully around the ‘unusual blood clots’ issue.

In December 2021 (and somewhat late to the party) a group of also-ran researchers at Cardiff and Arizona State Universities also announced that they had identified a clotting issue, and claimed to have found the cause; linking it to the adenovirus used in the product and its potential to bind with a blood product called platelet factor 4 (PF4). Their research also showed that due to use of the same adenovirus, this was the reason the Johnson & Johnson (J&J) covid product administered in the United States of America (USA) also demonstrated a high rate of clot-related adverse events.

It was noteable that after both announcements the UK Government records¹ that the Gates Foundation² (here and here) and Pharma-funded³ UK Medicines and Healthcare products Regulatory Authority (MHRA) who authorised the ChadOx1 (now known as Vaxzevaria) product in the UK during June 2021, still held firm to the claim that the vaccine was almost infallible, and that the ‘benefits far outweighed the risk of any known side effects’.

Leaving aside that the footnotes to this article show that the MHRA had received close to £12million reasons during 2020-2021 to keep repeating this clearly inappropriate, incorrect and misleading mantra - try telling it to the hundreds of people who died or suffered permanent disabilities from receiving either the AZ or J&J products.

It takes very little effort to identify in publicly available coronial reports and the mainstream media a large number of individuals and families affected by the same thromboembolic reactions after receiving the AZ Covid-19 injection. My own limited research conducted in the five days since the High Court case was announced in the media has turned up a dataset of over 130 different named individuals described in news reports, coronial reports and post mortem findings as having died from a thromboembolic adverse reaction with thrombocytopaenia following injection of the AZ product, and where the AZ product is specifically named as the causative agent.

In order to give names to the numbers, these are 15 names selected at random from that dataset who coroners have ruled died as a direct result of receiving the AZ product:

• 27 year old Jack Last from Suffolk (Coronial finding).

• 18 year old Kasey Turner from Barnsley (Coronial finding).

• 26 year old Oli Hoque from Goodmayes (Coronial finding).

• 26 year old Jack Hurn from Birmingham (Coronial finding).

• 34 year old Kim Lockwood from Rotherham (Coronial finding).

• 51 year old Michelle Barlow from Orrell (Coronial finding).

• 41 year old Adam Bounds from Plymouth (Coronial finding).

• 44 year old Lisa Shaw of the BBC (Coronial finding).

• 59 year old Neil Astles (Coronial finding).

• 38 year old Kelly Dunley from Stoke-on-Trent (Coronial finding).

• 44 year old William Reed who was on holiday on the East Coast of Tasmania (Coronial finding).

• 48 year old Zion of Newcastle (Coronial finding).

• 31 year old Tom Dudley from Sheffield (Coronial finding).

• 48 year old Helena Ashton from St Leonards-on-Sea (Coronial finding).

• 40 year old Mathew Dibble of London (Coronial finding).

When giving evidence during the coronial inquest into the AZ-related death of Neil Astles, Jonathan Dixey appearing for the MHRA acknowledged that as of October 27, 2021 - and only 4 months into the AZ UK campaign⁴, there had been 424 reports of thromboembolic events with concurrent thrombocytopaenia linked to the AZ Covid-19 product, of which at that time 72 had been fatal.

That suggests a frequency of event in just the UK over those four months of around:

106 AZ-related thromboembolic AEs per calendar month

Resulting in at least:

4.2 AZ-related thromboembolic deaths per week.

Hardly rare.

Vaccine recalls

Other vaccines have been recalled and withdrawn from supply for producing less severe numbers of adverse effects or deaths:

1. LYMErix was withdrawn by GSK who sought to gaslight consumers by claiming that negative press had caused ‘poor market performance’. However, the truth was that it was that post-marketing monitoring linked the vaccine to 905 reports of mild self-limiting reactions and 59 reports of vaccine-induced arthritis, and long-term or chronic disease in a small number of recipients. Like the Covid-19 products, LYMErix was another example of a vaccine rushed to market without adequate and long-term safety testing.

2. Around 200 soldiers in basic training at Fort Dix fell ill after administration of the 1976 H1N1 swine flu vaccine. The CDC reported that at least four soldiers were hospitalised with serious pneumonia, and one died. Public health experts panicked and proclaimed a pandemic was coming that would be worse than 1918. President ford released almost $70mil to rush development and release of a vaccine that was ‘ready’ several months later. However, while no pandemic materialised over 48mil people were vaccinated with the 1976 Swine Flu vaccine. By the end of 1976 there were more than 1098 reports of Guillian-Barre Syndrome (GBS) – which national health experts wrote off as an estimated rate of 1 in 100,000 vaccinations and claimed was not higher than the background incidence (source). After 20% of the US population had been jabbed the vaccine was stopped, and the whole matter described as a ‘sorry debacle’ and a ‘fiasco’ that it was claimed had ‘discredited preventative medicine’. While fact checkers like to say there is ‘no evidence’ (here), the former head of the CDC said the 1976 Swine Flu vaccine was recalled after “at least 25 people (and as many as 32) had died from vaccine reactions” (source). The number, 32 deaths, is backed up by this academic report (source).

3. In 2009 the CDC rushed to recall 800,000 doses of Sanofi Pasteur’s 2009 H1N1 Swine Flu Vaccine intended for administration to children. The headline issue was that the potency of the vaccine during manufacture had dropped from 18 to 12 percent (a 6 percent drop). SP laughably claimed that even though their factories and testers had all failed to identify the issue, that because academic investigators at a university serendipitously found it, this ‘is a measure of how carefully vaccines are checked’ (source).

4. In 2020 Singapore withdrew both SK Bioscience’s SKYCellflu and Sanofi Pasteur’s VaxigripTetra vaccines after they were found to have caused the deaths of at least 59 of the estimated 14.7mil vaccine recipients. Sanofi sought to claim that the deaths were not linked to their vaccine but the withdrawal went ahead anyway (source).

5. CSL Biotherapies withdrew their FluVax vaccine after a study showed there was an increased risk of harm to children. Children in two states were becoming sick within 24 hours after receiving the vaccine with fever and convulsions at a rate of 9 in 1000 when the expected rate should have been less than 1 in 1000 (source).

6. Pfizer-Vax Measles–K, Pfizer’s inactivated measles virus vaccine given in a series of three vaccines at one month intervals, was much less reactive but the vaccine offered limited effectiveness against the disease. In fact, the majority of children who received the vaccine had no detectable levels of measles antibodies when tested one year later. By 1965, doctors were reporting of a new and abnormal measles-like illness (atypical or vaccine-induced measles) in children previously vaccinated with the Measles-K vaccine upon exposure to measles. Symptoms of atypical measles included rash, swelling, fever, pneumonia, and pleural effusion. Measles-K vaccine was removed from the market in 1968 (source, source and source). There are several papers written in the 1970s and 80s that describe ongoing and even elevated rates of related atypical (vaccine-induced) measles infections and deaths in children (here, here and here).

7. An increased risk of narcolepsy was found following vaccination with GSK’s Pandemrix, a 2009 H1N1 vaccine. VAERS was one of the databases used to identify cases (source). Interestingly, a BMGF and similar funder study in 2018 sought to reverse the finings by claiming that there was not a rise in narcolepsy cases (source) even though a PHE study showed narcolepsy in 1 in 55,000 people could be blamed on the vaccine, and a 2017 court ruling had ruled Pandemrix caused the narcolepsy of a 7yo boy, and in 2014 the narcolepsy of a man called john – with each receiving £120,000 (source). A court found GSK had failed to warn recipients of Pandemrix’s issues that they knew of from internal safety reports (source). In all, a BMJ study showed Pandemrix caused 72 cases per million doses of serious adverse events, seven times that of a similar vaccine (GSK’s Arepanrix) (source). GSK requested withdrawal of Arepanrix in late 2010 and Pandemrix has not been available since 2015 (source).

8. An estimated 120,000 children received the Cutter Polio vaccine with 1 in 3 (40,000) suffering ‘abortive’ polio as a result. Fifty-one children were paralysed with polio and 5 died before the vaccine could be recalled (source).

9. While an antiviral, in some countries (like Australia) Roche’s Tamiflu was administered to young children as a vaccine (prophylaxis). Roche withheld vital information about Tamiflu for more than 5 years, including the fact that Tamiflu has little or no impact on complications of flu infection, such as pneumonia (source). One study saw 119 deaths after administration of Tamiflu (source), while others report that the vaccine caused neuropsychiatric disturbances in adolescents and resulted in at least 50, and as many as 71, deaths (source and source). Investigations also looked into deaths of babies and infants that were laid before the injections and oral suspension (source).

This list contains eleven examples of vaccines that caused harm and, as a result, were recalled and removed from sale (points 4 and 7 each contain two vaccines that were recalled). Consider how many hundreds of millions of children’s lives were seriously and chronically impacted by administration of these toxic, recalled, compounds. Vaccines are medicines, just like viagra, vioxx or fentanyl. In spite of Matt Hancock’s totally ridiculous claim that there would be no adverse reactions from the AZ covid-19 injectable product, no medication in history has ever been completely free of side effects.

The government, politicians, regulators, manufacturers and even your local GP all colluded to mislead you regarding the safety and effectiveness of the Covid-19 injectable products. We can only hope that those who were harmed, including families of the deceased, are adequately and significantly compensated for the harm wrought upon them.

*** ADDENDUM

Thanks to Dr Clare Craig for spotting that I had accidentally pasted the final two sentences and associated references from the 1976 Swine Flu paragraph into the 2009 Swine Flu paragraph by mistake. I have corrected this.

Also, based on a question from Clare I have added a reference and screenshot from a UK Government publication supporting my statement regarding the MHRA only getting around to giving CMA for the Astrazeneca jab in June 2021.

***

1. https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca

2. Why is this important? Because Bill and Melinda Gates had also invested heavily in each of the Covid-19 ‘vaccine’ products and therefore had a vested interest in getting regulators to approve them. Overall, Bill Gates is said to have profited at a rate of at least 10-to-1 for every dollar he and his foundation invested in Covid products - for example, investing $50million in one producer for shares that he later sold for just over $500million. FOI releases show that Gates’ Foundation provided over £3million in funding to the MHRA during the relevant period from March 2020 to June 2021. It could be said that CMA approval was ‘for sale’ in the UK if the price was right.

3. Why is this important? The MHRA have been deceptive and disingenuous with responses regarding the funding and revenues they receive from large pharmaceutical organisations - in some cases asking the same clarifying questions repeatedly, claiming it is too hard or complex to answer the FOI requests, taking more than five months to provide a dispositive response and eventually only providing a small subset of data that demonstrates they receive as much as £1mil per annum from Pfizer alone (here). More recent FOI responses have seen that the five Covid product manufacturers gave the MHRA almost £9mil during the period from 2020-2021 (here).

4. While the EMA had given authorisation for the AZ ChadOx1 product from January 29, 2021 in Ireland, the UK MHRA only issued Conditional Marketing Authorisation under Regulation 174 of the Human Medicine Regulation 2012 for the AZ Covid product on June 24, 2021.